Stock Scorer
Stock Board CompareNew Screen Insiders ETFNew
Donate
…
Report Measures Companies Earnings calendar Insider buying Fund portfolios Congress trades ETFs
Sign in

UroGen Pharma Ltd. (URGN) · Insider trading

What UroGen Pharma's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$4.77M
3 insiders, 27% under a plan
Net, 12 months
−$4.77M
bought less sold
Latest filing
2026-10-09
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01: $132,900 sold 2025-01 2025-06: $38,044 sold 2025-07: $242,523 sold 2025-07 2025-08: $176,900 sold 2025-09: $45,692 sold 2025-10: $37,121 sold 2025-11: $250,000 sold 2026-01 2026-02: $292,436 sold 2026-05: $300,000 sold 2026-06: $492,661 sold 2026-07: $400,000 sold 2026-07 2026-08: $2.85M sold 2026-09: $102,002 sold 2026-10: $80,791 sold
Bought Sold Largest month: $2.85M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Schoenberg MarkChief Medical Officer – $4.86M 17 2026-09-08 59,882
Smith Jason DrewGeneral Counsel – $467,100 9 2026-09-08 53,141
Degnan ChrisChief Financial Officer – $117,912 2 2026-10-08 4,561

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-10-08 Degnan ChrisChief Financial Officer Sale 2,202 36.69 $80,791 4,561 Form 4
2026-09-08 Smith Jason DrewGeneral Counsel Sale 1,519 42.54 $64,618 53,141 Form 4
2026-09-08 Schoenberg MarkChief Medical Officer Sale 871 42.92 $37,383 59,882 Form 4
2026-08-20 Schoenberg MarkChief Medical Officer Sale 60,677 47.05 $2.85M 59,086 Form 4
2026-07-09 Schoenberg MarkChief Medical Officer Saleplan 10,000 40.00 $400,000 119,763 Form 4
2026-06-22 Schoenberg MarkChief Medical Officer Saleplan 10,000 35.01 $350,100 129,763 Form 4
2026-06-08 Schoenberg MarkChief Medical Officer Sale 5,222 27.30 $142,561 139,763 Form 4
2026-05-08 Schoenberg MarkChief Medical Officer Saleplan 10,000 30.00 $300,000 134,985 Form 4
2026-02-03 Smith Jason DrewGeneral Counsel Sale 2,654 19.69 $52,257 52,934 Form 4
2026-02-03 Smith Jason DrewGeneral Counsel Sale 1,608 19.69 $31,662 51,326 Form 4
2026-02-03 Smith Jason DrewGeneral Counsel Sale 3,217 19.69 $63,343 55,588 Form 4
2026-02-03 Schoenberg MarkChief Medical Officer Sale 1,844 19.69 $36,308 150,514 Form 4
2026-02-03 Schoenberg MarkChief Medical Officer Sale 1,843 19.69 $36,289 148,671 Form 4
2026-02-03 Schoenberg MarkChief Medical Officer Sale 3,686 19.69 $72,577 144,985 Form 4
2025-11-19 Schoenberg MarkChief Medical Officer Saleplan 10,000 25.00 $250,000 139,025 Form 4
2025-10-08 Degnan ChrisChief Financial Officer Sale 2,203 16.85 $37,121 2,280 Form 4
2025-09-08 Smith Jason DrewGeneral Counsel Sale 1,520 19.11 $29,047 43,305 Form 4
2025-09-08 Schoenberg MarkChief Medical Officer Sale 871 19.11 $16,645 149,025 Form 4
2025-08-11 Schoenberg MarkChief Medical Officer Sale 10,000 17.69 $176,900 148,229 Form 4
2025-07-28 Schoenberg MarkChief Medical Officer Sale 5,149 19.14 $98,552 158,229 Form 4
2025-07-28 Smith Jason DrewGeneral Counsel Sale 7,522 19.14 $143,971 41,492 Form 4
2025-06-09 Schoenberg MarkChief Medical Officer Sale 5,162 7.37 $38,044 153,378 Form 4
2025-01-31 Smith Jason DrewGeneral Counsel Sale 1,258 11.14 $14,014 26,468 Form 4
2025-01-31 Smith Jason DrewGeneral Counsel Sale 3,354 11.14 $37,364 29,781 Form 4
2025-01-31 Smith Jason DrewGeneral Counsel Sale 2,767 11.14 $30,824 32,514 Form 4
2025-01-31 Schoenberg MarkChief Medical Officer Sale 759 11.14 $8,455 145,666 Form 4
2025-01-31 Schoenberg MarkChief Medical Officer Sale 1,896 11.14 $21,121 147,103 Form 4
2025-01-31 Schoenberg MarkChief Medical Officer Sale 1,896 11.14 $21,121 148,540 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

30 × option exercise
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-10-08 Degnan ChrisChief Financial Officer Option exercise M +4,483 – 6,763 Form 4
2026-09-07 Smith Jason DrewGeneral Counsel Option exercise M +3,334 – 54,660 Form 4
2026-09-07 Schoenberg MarkChief Medical Officer Option exercise M +1,667 – 60,753 Form 4
2026-08-26 Robinson James A. Jr.Director Option exercise M +2,000 – 8,000 Form 4
2026-06-08 Schoenberg MarkChief Medical Officer Option exercise M +10,000 – 144,985 Form 4
2026-05-26 Robinson James A. Jr.Director Option exercise M +2,000 – 6,000 Form 4
2026-01-31 Smith Jason DrewGeneral Counsel Option exercise M +5,500 – 55,472 Form 4
2026-01-31 Smith Jason DrewGeneral Counsel Option exercise M +3,333 – 58,805 Form 4
2026-01-31 Smith Jason DrewGeneral Counsel Option exercise M +6,667 – 49,972 Form 4
2026-01-31 Schoenberg MarkChief Medical Officer Option exercise M +3,333 – 145,692 Form 4
2026-01-31 Schoenberg MarkChief Medical Officer Option exercise M +6,666 – 152,358 Form 4
2026-01-31 Schoenberg MarkChief Medical Officer Option exercise M +3,334 – 142,359 Form 4
2025-11-26 Wildman Daniel GeorgeDirector Option exercise M +2,000 – 2,000 Form 4
2025-11-26 Wen LeanaDirector Option exercise M +2,000 – 2,000 Form 4
2025-11-26 Robinson James A. Jr.Director Option exercise M +2,000 – 2,000 Form 4
2025-11-26 Butitta Cynthia MDirector Option exercise M +2,000 – 2,000 Form 4
2025-11-26 Holden StuartDirector Option exercise M +2,000 – 2,000 Form 4
2025-10-08 Degnan ChrisChief Financial Officer Option exercise M +4,483 – 4,483 Form 4
2025-09-07 Smith Jason DrewGeneral Counsel Option exercise M +3,333 – 44,825 Form 4
2025-09-07 Schoenberg MarkChief Medical Officer Option exercise M +1,667 – 149,896 Form 4
2025-07-28 Schoenberg MarkChief Medical Officer Option exercise M +10,000 – 163,378 Form 4
2025-07-28 Smith Jason DrewGeneral Counsel Option exercise M +16,500 – 49,014 Form 4
2025-06-08 Schoenberg MarkChief Medical Officer Option exercise M +10,000 – 158,540 Form 4
2025-02-26 Robinson James A. Jr.Director Option exercise M +2,000 – 4,000 Form 4
2025-01-31 Smith Jason DrewGeneral Counsel Option exercise M +2,500 – 27,726 Form 4
2025-01-31 Smith Jason DrewGeneral Counsel Option exercise M +6,667 – 33,135 Form 4
2025-01-31 Smith Jason DrewGeneral Counsel Option exercise M +5,500 – 35,281 Form 4
2025-01-31 Schoenberg MarkChief Medical Officer Option exercise M +1,334 – 146,425 Form 4
2025-01-31 Schoenberg MarkChief Medical Officer Option exercise M +3,333 – 148,999 Form 4
2025-01-31 Schoenberg MarkChief Medical Officer Option exercise M +3,333 – 150,436 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

UroGen Pharma's scores and multiples ›